New device can help test treatments in patients with gliomas

The shape and size of a grain of rice, the new device can conduct dozens of experiments at once to study the effects of new treatments on some of the hardest-to-treat brain cancers.

Corrected: Prime Medicine partners with Versant-backed biotech to develop safer stem cell transplants

Prime Medicine and Cimeio Therapeutics are partnering to develop gene-edited stem cell treatments for two kinds of bone marrow cancers and other potential genetic diseases,

June 23, 2023

How the gut microbiome contributes to schizoprhrenia

Researchers explore potential relationships between schizophrenia, the gut microbiome, the gut-brain axis, and short-chain fatty acids.

October 19, 2023

Opinion | Let’s Make Primary Care a Primary Focus

Fred Pelzman is an associate professor of medicine at Weill Cornell, and has been a practicing internist for nearly 30 years. He is medical director

July 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.